SCHEMBL29420191

SCHEMBL29420191

Fc1ccc(F)c(C2=NCCC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 7/20 0.49
CHRNA3 P32297 7/20 0.49
POLB P06746 2/20 0.41
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
THRB P10828 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
HK1 P19367 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HDAC8 Q9BY41 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1429750 1.00 CHRNB4 (0.49) CHRNB4CHRNA3POLBALDH1A1LMNA
Methyl Alcohol SCHEMBL28796119 0.95 CHRNB4 (0.45) CHRNB4CHRNA3POLBALDH1A1LMNA
SCHEMBL17353143 0.95 CHRNB4 (0.56) CHRNB4CHRNA3POLBALDH1A1LMNA
Trifluoroacetic Acid SCHEMBL22578586 0.87 KIF11 (0.40) CHRNB4CHRNA3POLBKIF11
SCHEMBL22097422 0.82 NISCH (0.51) CHRNB4CHRNA3POLBALDH1A1THRB
SCHEMBL38652147 0.82 CHRNB4 (0.46) CHRNB4CHRNA3ALDH1A1THRBMAPT
SCHEMBL29867681 0.82 KIF11 (0.37) CHRNB4CHRNA3POLBALDH1A1LMNA
SCHEMBL22039419 0.79 CHRNB4 (0.46) CHRNB4CHRNA3POLBALDH1A1THRB
SCHEMBL1344342 0.79 CHRNB4 (0.46) CHRNB4CHRNA3POLBALDH1A1THRB
SCHEMBL21510308 0.78 CHRNB4 (0.43) CHRNB4CHRNA3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114774383-B Imine reductase mutant and application thereof in catalytic synthesis of chiral 2-arylpyrrolidine 安徽趣酶生物科技有限公司 2024-03-12 CN claimed
CN-110283858-B Method for preparing (S) -2- (2, 5-difluorophenyl) pyrrolidine by biocatalysis 尚科生物医药(上海)有限公司 2024-01-26 CN claimed
CN-111057729-B (R) -2- (2, 5-difluorophenyl) pyrrolidine and preparation method and application thereof 弈柯莱生物科技(上海)股份有限公司 2023-08-29 CN claimed
CN-114836490-A Application of imine reductase in catalytic synthesis of chiral 2-aryl pyrrolidine 上海健康医学院 2022-08-02 CN claimed
CN-113354649-B Novel crystal form 阵列生物制药公司 2024-12-10 CN disclosed
CN-109414442-B Liquid preparation of compound 洛克索肿瘤学股份有限公司 2024-03-29 CN disclosed
CN-114774383-B Imine reductase mutant and application thereof in catalytic synthesis of chiral 2-arylpyrrolidine 安徽趣酶生物科技有限公司 2024-03-12 CN disclosed
CN-110283858-B Method for preparing (S) -2- (2, 5-difluorophenyl) pyrrolidine by biocatalysis 尚科生物医药(上海)有限公司 2024-01-26 CN disclosed
CN-110283858-B Method for preparing (S) -2- (2, 5-difluorophenyl) pyrrolidine by biocatalysis 尚科生物医药(上海)有限公司 2024-01-26 CN disclosed
CN-111057729-B (R) -2- (2, 5-difluorophenyl) pyrrolidine and preparation method and application thereof 弈柯莱生物科技(上海)股份有限公司 2023-08-29 CN disclosed
CN-111057729-B (R) -2- (2, 5-difluorophenyl) pyrrolidine and preparation method and application thereof 弈柯莱生物科技(上海)股份有限公司 2023-08-29 CN disclosed
CN-114163445-B Larotinib intermediate and preparation method thereof 重庆医科大学 2023-06-20 CN disclosed
CN-111138333-B Preparation method of (R) -2- (2, 5-difluorophenyl) -pyrrolidine 上海复星星泰医药科技有限公司 2023-05-23 CN disclosed
CN-115704014-A Imine reductase mutant and application thereof in synthesis of (R) -2- (2, 5-difluorophenyl) pyrrolidine 陈泽聪 2023-02-17 CN disclosed
CN-115704043-A Method for preparing (R) -2- (2,5-difluorophenyl) pyrrolidine 陈泽聪 2023-02-17 CN disclosed
CN-114836490-A Application of imine reductase in catalytic synthesis of chiral 2-aryl pyrrolidine 上海健康医学院 2022-08-02 CN disclosed
CN-114774383-A Imine reductase mutant and application thereof in catalytic synthesis of chiral 2-aryl pyrrolidine 上海健康医学院 2022-07-22 CN disclosed
CN-111302997-B Method for preparing Raatinib intermediate by one-pot method 江苏恒沛药物科技有限公司 2022-03-29 CN disclosed
CN-114163445-A Raatinib intermediate and preparation method thereof 重庆医科大学 2022-03-11 CN disclosed